You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune checkpoint inhibitor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Anlotinib and TQB2450
  • Shanghai, Shanghai, China
    Zhongshan hospital
Sep 4, 2023

Adverse Events-related Healthcare Resource Utilization and Costs

Completed
  • Melanoma
  • East Hanover, New Jersey
    Novartis Pharmaceuticals
Jan 27, 2023

Solid Tumor, Hematologic Malignancy Trial in Beijing (Eliglustat, Immune checkpoint inhibitor)

Recruiting
  • Solid Tumor
  • Hematologic Malignancy
  • Beijing, China
    Department of Biotherapeutic, Chinese PLA General Hospital
Apr 28, 2022

Genito-Urinary Tumor Trial in Duarte (Biospecimen Collection(Punch Biopsy))

Active, not recruiting
  • Genito-Urinary Neoplasm
  • Biospecimen Collection(Punch Biopsy)
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Pneumonitis Trial in Chongqing (single-cell sequencing)

Not yet recruiting
  • Pneumonitis
  • single-cell sequencing
  • Chongqing, Chongqing, China
    Xinqiao Hospital
Jul 12, 2022

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, China
  • +1 more
Mar 28, 2023

Quality of Life and Physical Fitness After Immune Checkpoint

Completed
  • Melanoma
  • Non Small Cell Lung Cancer
    • Groningen, Netherlands
      University Medical Center Groningen
    Jan 3, 2023

    Cancer, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors Trial in Zurich (Fecal Microbiota Transplantation (FMT))

    Recruiting
    • Cancer
    • +2 more
    • Fecal Microbiota Transplantation (FMT)
    • Zurich, Switzerland
      University of Zurich, University Hospital Zurich
    Jun 14, 2022

    Immune Checkpoint Inhibitor, Lung Cancer, Liver Biomarkers Trial in Amiens (Blood sample)

    Recruiting
    • Immune Checkpoint Inhibitor
    • +3 more
    • Blood sample
    • Amiens, France
      CHU Amiens
    Dec 8, 2022

    Colitis, Diarrhea, Malignant Genitourinary System Tumor Trial in Houston (Fecal Microbiota Transplantation, Loperamide)

    Recruiting
    • Colitis
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 17, 2022

    Solid Tumor, Adult Trial (IMSA101, Immune Checkpoint Inhibitor)

    Not yet recruiting
    • Solid Tumor, Adult
    • (no location specified)
    Sep 6, 2023

    Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

    Not yet recruiting
    • Metastatic Melanoma
    • Advanced Melanoma
    • San Francisco, California
      University of California, San Francisco
    Jan 13, 2023

    NSCLC, Immune Checkpoint Inhibitors Trial in Seoul (F-18 FDG PET/CT)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Immune Checkpoint Inhibitors
    • F-18 FDG PET/CT
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 15, 2022

    Suspicion of Cardiovascular Events on Immunecheckpoint

    Recruiting
    • Cancer
    • +3 more
    • No intervention for research purposes only
    • Paris, France
      Intitut Mutualiste Montsouris
    Mar 23, 2023

    Chemotherapy Combined With Immunotherapy or Chemotherapy

    Completed
    • Non-small Cell Lung Cancer
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Mar 9, 2022

    Intestinal Biomarker Analysis After ECP for ICI Colitis

    Recruiting
    • Colitis
    • Immune Checkpoint Inhibitor-Related Colitis
    • Intestinal tissue analysis
    • Freiburg, Baden Württemberg, Germany
      Freiburg University Medical Center
    Oct 5, 2023

    The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in

    Recruiting
    • Non-Small-Cell Lung Carcinoma
    • +3 more
    • Checkpoint Inhibitor, Immune
    • Elizabethtown, Kentucky
      Baptist Health Clinical Research
    Apr 25, 2022

    Urogenital Cancer Trial in London (Atezolizumab)

    Recruiting
    • Urogenital Cancer
    • London, United Kingdom
      Barts and London Hospital NHS Trust
    Aug 10, 2022

    Colorectal Tumors Malignant Trial in Beijing (Fecal microbiota transplantation plus Sintilimab and Fruquintinib)

    Recruiting
    • Colorectal Neoplasms Malignant
    • Fecal microbiota transplantation plus Sintilimab and Fruquintinib
    • Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Aug 21, 2022

    Oligometastatic Disease Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

    Not yet recruiting
    • Oligometastatic Disease
    • (no location specified)
    May 5, 2023

    Oligoprogressive Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

    Not yet recruiting
    • Oligoprogressive
    • (no location specified)
    May 5, 2023

    Prediction in Solid Tumors

    Recruiting
    • Malignant Solid Neoplasm
    • Biospecimen Collection
    • Questionnaire Administration
    • Ames, Iowa
    • +5 more
    Sep 7, 2022

    Non Small Cell Lung Cancer Trial in Montréal (increasing total fiber intake)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • increasing total fiber intake
    • Montréal, Quebec, Canada
      Centre hospitalier de l'Université de Montréal (CHUM)
    Apr 6, 2023

    The Gut Immune System During Immune Checkpoint Inhibitor Therapy

    Recruiting
    • Cancer
    • sigmoidoscopies and and venous blood sampling
    • Groningen, Netherlands
      University Medical Center Groningen
    Jan 4, 2022

    Microbiome on Immune Checkpoint Inhibitor Response in Melanoma

    Active, not recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • Pathologic Stage IV Cutaneous Melanoma AJCC v8
    • Biospecimen Collection
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    May 31, 2022